International Cannabis Weekly: 463

 

GERMANY’S MEDICAL CANNABIS INSURANCE REFORM DESCENDS INTO CHAOS AS REGULATORS TURN ON EACH OTHER

Last month, the German government passed a controversial cost-saving law that saw tens of thousands of patients denied access medical cannabis to flower reimbursed through statutory health insurance (GKV).

READ MORE  »

AURORA ACCUSES CURALEAF OF ‘PRESSURING SHAREHOLDERS’

READ MORE »

ISREAL REOPENS ITS CANADIAN CANNABIS DUMPING CASE

READ MORE »

• Ireland’s Dunbar Pharma launches plant-derived dronabinol in the UK through IPS Pharma.
• Lower Saxony reaches milestone with 100 cannabis cultivation associations now approved.
• German initiative launches campaign against proposed removal of cannabis reimbursement coverage.
• Portugal’s Liberal Initiative questions government over medical cannabis and CBD product seizures.
• Tilray Medical welcomes progress in Germany’s medical cannabis framework and continued policy development.
• Medicinal cannabis growers in Jersey call for changes to island packaging regulations.

LEARN MORE »

• Bipartisan lawmakers press Trump for guidance on cannabis rescheduling and Medicare coverage.
• Massachusetts Democratic voters strongly oppose ballot measure seeking to roll back marijuana legalization.
• Charlotte’s Web sales fall 15% as intoxicants crackdown accelerates healthcare-focused business pivot.
• Illinois adult-use cannabis retailers can seek medical permits with potential DEA and tax benefits.
• Georgia considers legalising medical cannabis deliveries as access rules face potential changes.
• Medical cannabis home cultivation licences face new developments across the United States.
• Green Check expands beyond cannabis banking into compliance for high-risk specialty industries.

• Canadian hemp production shifts back toward grain as CBD flower fields and fibre retreat.
• Canada’s cannabis industry calls for improved market intelligence tosupport future growth.
• Canadian government launches new consortium examining cannabis use and brain health research.
• Cannabis NB unveils new strategic plan focused on strengthening New Brunswick’s cannabis market.
• XLY becomes Canada’s second-largest cannabis producer with $166 million revenue reported.
• Canopy Growth secures renewed EU-GMP certification as European medical cannabis business expands.

• Mexican cannabis association pushes for greater access to personal cultivation rights.
• Brazilian federal council expands biomedical activities across the country’s cannabis supply chain.
• São Paulo cannabis programme marks two years as lawmakers debate its future direction.
• Brazil is seeing a 29% increase in requests to import medical cannabis products.

• Australian cannabis prices continue falling as total product numbers approach 2,000.
• Gandaki passes cannabis law but faces tougher challenges implementing the new framework.
• Driving reform pressure is building in Western Australia ahead of planned cannabis rally.
• Nepal’s Gandaki province explores cannabis economy following passage of landmark legislation.

• IM Cannabis enters agreement to sell holdings and European-focused cannabis assets.